Reducing the burden of skin toxicity in children receiving targeted immunotherapy for neurofibromatosis Type 1 (NF1) This listing has expired.
Understanding the molecular control of microglia in Alzheimer’s disease Cardiff University, Cardiff, United Kingdom Closing date: August 21, 2026
Mitochindrial DNA repair The University of Birmingham, Birmingham, United Kingdom Closing date: September 27, 2026
Development of a Human Cholinergic Co-culture Model to Investigate α-Synuclein-Induced Neurodegeneration in Parkinson’s Disease Dementia and Dementia with Lewy Bodies The University of Birmingham, Birmingham, United Kingdom Closing date: September 27, 2026
Identifying critical pathways regulating autoimmunity in immuno-oncology and arthritis patients The University of Manchester, Manchester, United Kingdom Closing date: August 18, 2026
Understanding health conditions linked to psoriatic disease across diverse populations The University of Manchester, Manchester, United Kingdom Closing date: August 18, 2026
FULLY FUNDED PhD – Combination treatment with advanced therapies and enteral nutrition in children with active Crohn’s disease University of Glasgow, Glasgow, United Kingdom Closing date: August 15, 2026
